|
[1]
|
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组. 中国抗癌协会乳腺癌诊治指南与规范(2024年版) [J]. 中国癌症杂志, 2023, 33(12): 1092-1187.
|
|
[3]
|
赵健洁, 张晓华, 郝帅, 等. 雌激素受体阳性乳腺癌内分泌治疗疗效预测标志物研究进展[J]. 重庆医科大学学报, 2019, 44(12): 1542-1546.
|
|
[4]
|
李开春, 王雅杰. 激素受体阳性晚期乳腺癌内分泌治疗选择[J]. 肿瘤学杂志, 2020, 26(1): 7-12.
|
|
[5]
|
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2015) Aromatase Inhibitors versus Tamoxifen in Early Breast Cancer: Patient-Level Meta-Analysis of the Randomized Trials. Lancet, 386, 1341-1352. [Google Scholar] [CrossRef]
|
|
[6]
|
Chan, C.W.H., Tai, D., Kwong, S., Chow, K.M., Chan, D.N.S. and Law, B.M.H. (2020) The Effects of Pharmacological and Non-Pharmacological Interventions on Symptom Management and Quality of Life among Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy: A Systematic Review. International Journal of Environmental Research and Public Health, 17, Article 2950. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Condorelli, R. and Vaz-Luis, I. (2018) Managing Side Effects in Adjuvant Endocrine Therapy for Breast Cancer. Expert Review of Anticancer Therapy, 18, 1101-1112. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ibrar, M., Peddie, N., Agnew, S., Diserholt, A. and Fleming, L. (2022) Breast Cancer Survivors’ Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence. Frontiers in Psychology, 13, Article 861198. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Peddie, N., Agnew, S., Crawford, M., Dixon, D., MacPherson, I. and Fleming, L. (2021) The Impact of Medication Side Effects on Adherence and Persistence to Hormone Therapy in Breast Cancer Survivors: A Qualitative Systematic Review and Thematic Synthesis. The Breast, 58, 147-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Zhu, Z., Xing, W., Hu, Y., Wu, B. and So, W.K.W. (2022) Paradigm Shift: Moving from Symptom Clusters to Symptom Networks. Asia-Pacific Journal of Oncology Nursing, 9, 5-6. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
文翠菊, 王玥妮, 孙红娟, 等. 乳腺癌患者芳香化酶抑制剂治疗期间症状群及影响因素分析[J]. 中国实用护理杂志, 2022, 38(2): 132-139.
|
|
[12]
|
Jing, F., Zhu, Z., Qiu, J., Tang, L., Xu, L., Xing, W., et al. (2023) Symptom Clusters and Quality of Life in Patients with Breast Cancer Receiving Endocrine Therapy in China. Seminars in Oncology Nursing, 39, Article ID: 151443. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Agnew, S., Crawford, M., MacPherson, I., Shiramizu, V. and Fleming, L. (2024) The Impact of Symptom Clusters on Endocrine Therapy Adherence in Patients with Breast Cancer. The Breast, 75, Article ID: 103731. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Lenz, E.R., Suppe, F., Gift, A.G., Pugh, L.C. and Miligan, R.A. (1995) Collaborative Development of Middle-Range Nursing Theories: Toward a Theory of Unpleasant Symptoms. Advances in Nursing Science, 17, 1-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
李晴晴, 倪建芬, 方群英, 等. 乳腺癌内分泌治疗患者症状评估量表的编制和信效度检验[J]. 中华护理杂志, 2021, 56(6): 880-886.
|
|
[16]
|
Kim, H., Barsevick, A.M., Tulman, L. and McDermott, P.A. (2008) Treatment-Related Symptom Clusters in Breast Cancer: A Secondary Analysis. Journal of Pain and Symptom Management, 36, 468-479. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
陈庆梅, 崔妙玲, 麻月娥, 等. 慢性阻塞性肺疾病急性加重期患者症状群及前哨症状的调查研究[J]. 中华护理杂志, 2022, 57(23): 2891-2897.
|
|
[18]
|
荆凤, 邢唯杰, 裘佳佳, 等. 乳腺癌患者内分泌治疗相关症状的调查研究[J]. 中华护理杂志, 2021, 56(5): 737-743.
|
|
[19]
|
巴东升, 郭扬, 陈波, 等. 乳腺癌术后内分泌治疗患者报告的核心伴随症状及对针灸治疗的需求: 一项基于网络的横断面研究[J]. 针刺研究, 2024, 49(7): 707-714.
|
|
[20]
|
Cucciniello, L., Garufi, G., Di Rienzo, R., Martinelli, C., Pavone, G., Giuliano, M., et al. (2023) Estrogen Deprivation Effects of Endocrine Therapy in Breast Cancer Patients: Incidence, Management and Outcome. Cancer Treatment Reviews, 120, Article ID: 102624. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Van Dyk, K., Joffe, H. and Carroll, J.E. (2021) Sleep and Endocrine Therapy in Breast Cancer. Current Opinion in Endocrine and Metabolic Research, 18, 165-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Brajkovic, L., Sladic, P. and Kopilaš, V. (2021) Sexual Quality of Life in Women with Breast Cancer. Health Psychology Research, 9, Article 1. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Accortt, E.E., Bower, J.E., Stanton, A.L. and Ganz, P.A. (2015) Depression and Vasomotor Symptoms in Young Breast Cancer Survivors: The Mediating Role of Sleep Disturbance. Archives of Women’s Mental Health, 18, 565-568. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Committee on Practice Bulletins-Gynecology (2012) ACOG Practice Bulletin No. 126: Management of Gynecologic Issues in Women with Breast Cancer. Obstetrics & Gynecology, 119, 666-682.
|
|
[25]
|
Sánchez-Borrego, R., Mendoza, N., Beltrán, E., Comino, R., Allué, J., Castelo-Branco, C., et al. (2013) Position of the Spanish Menopause Society Regarding the Management of Menopausal Symptoms in Breast Cancer Patients. Maturitas, 75, 294-300. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Górecki, M., Mackiewicz, J., Kufel-Grabowska, J., Doś, J., Pogoda, K., Ziętek, M., et al. (2025) Physiotherapy and Rehabilitation Are Not to Be Omitted in a Cancer Therapy Plan. Nowotwory. Journal of Oncology, 75, 379-388. [Google Scholar] [CrossRef]
|
|
[27]
|
van Driel, C., Stuursma, A., Schroevers, M., Mourits, M. and de Bock, G. (2019) Mindfulness, Cognitive Behavioural and Behaviour‐Based Therapy for Natural and Treatment‐Induced Menopausal Symptoms: A Systematic Review and Meta‐Analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 126, 330-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Shainhouse, J., Hwang, P.S.Y., Fontes, M. and Bao, T. (2025) Integrative Medicine in Breast Cancer Survivorship Care. Annals of Palliative Medicine, 14, 283-294. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Burrell, R.A., Kumar, S., Provenzano, E., Pike, C., Dayimu, A., McIntosh, S.A., et al. (2026) Evaluating Progesterone Receptor Agonist Megestrol Plus Letrozole for Women with Early-Stage Estrogen-Receptor-Positive Breast Cancer: The Window-Of-Opportunity, Randomized, Phase 2b, PIONEER Trial. Nature Cancer, 7, 194-206. [Google Scholar] [CrossRef]
|
|
[30]
|
Jing, F., Zhu, Z., Qiu, J., Tang, L., Xu, L., Xing, W., et al. (2023) Contemporaneous Symptom Networks and Correlates during Endocrine Therapy among Breast Cancer Patients: A Network Analysis. Frontiers in Oncology, 13, Article 1081786. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
和晓歌, 李欢溪, 路潜, 等. 乳腺癌内分泌治疗患者的同期症状网络分析[J]. 中华护理教育, 2024, 21(9): 1141-1147.
|